KIORA PHARMACEUTICALS, INC. Prepaid Expense, Current
KIORA PHARMACEUTICALS, INC. (KPRX) had Prepaid Expense, Current of $470.42 thousand as of 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2024-11-08
- 2024-09-30: Prepaid Expense, Current $470.42K.
- 2024-06-30: Prepaid Expense, Current $339.65K.
- 2024-03-31: Prepaid Expense, Current $206.67K.
- 2023-12-31: Prepaid Expense, Current $233.38K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2024-09-30 | $470.42K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $339.65K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $206.67K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $233.38K 10-Q · filed 2024-11-08 |
| 2023-09-30 | $239.39K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $266.50K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $488.95K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $343.07K 10-Q · filed 2023-11-09 |
| 2022-09-30 | $260.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.40M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $930.35K 10-Q · filed 2022-07-08 |
| 2021-12-31 | $606.52K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |